Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aimed at promoting the development of plastic surgery and enhancing collaboration among related disciplines [2]. Event Overview - The conference will feature a main forum, an innovation transformation competition final, and nine sub-forums, with a total expected attendance of around 500 participants [5][6]. - The event is organized by the Chinese Academy of Medical Sciences Plastic Surgery Hospital and the Beijing Eight Great Places Aesthetic Medical Technology Group [4]. Main Forum Agenda - The main forum will include a welcome address, opening speeches, and a series of thematic presentations covering topics such as innovative medical technology, marketing integration in medical devices, and advancements in skin chip technology [5][6][7]. - Notable speakers include leaders from various medical and technological institutions, discussing the intersection of innovation and medical aesthetics [6]. Innovation Transformation Competition - The competition will focus on showcasing innovative achievements in plastic surgery and aesthetic medicine, providing a platform for project and capital matchmaking [7]. - Projects will cover diverse areas including materials, devices, and digital applications, highlighting the journey from research to clinical application [7][8]. Investment and Financing Sub-Forum - A dedicated sub-forum on investment and financing in the aesthetic medicine sector will take place on November 2, featuring discussions on industry trends and investment opportunities [9][10]. - Key topics will include the current state of the aesthetic medicine industry, insights into the light medical beauty sector, and strategies for integrating upstream and downstream resources [10]. Additional Forums - Various sub-forums will address topics such as medical device safety, digital transformation in aesthetic medicine, and regenerative medicine applications, with specific sessions dedicated to emerging technologies and investment strategies [22][24][33].

Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aimed at promoting the development of plastic surgery and enhancing collaboration among related disciplines [2]. Event Overview - The conference will feature a main forum, an innovation transformation competition final, and nine sub-forums, with a total expected attendance of around 500 participants [5][6]. - The event is organized by the Chinese Academy of Medical Sciences Plastic Surgery Hospital and the Beijing Eight Great Places Aesthetic Medical Technology Group [4]. Main Forum Agenda - The main forum will include a welcome address, opening speeches, and a series of thematic presentations covering topics such as innovative medical technology, marketing integration in medical devices, and applications of skin chip technology in plastic surgery [6][7]. - Notable speakers include executives from various medical and technological institutions, discussing advancements and commercialization in the field [6]. Innovation Transformation Competition - The competition will focus on innovative achievements in plastic surgery and aesthetic medicine, showcasing projects that span materials, devices, and digital applications [7]. - The agenda includes project presentations and a technology showcase, highlighting cutting-edge developments in the industry [8]. Investment and Financing Sub-Forum - A dedicated sub-forum will address the current state and opportunities in the aesthetic medicine industry from an investment perspective, featuring insights from investment professionals [9][10]. - Topics will include trends in the light aesthetic medicine sector and strategies for integrating the industry’s supply chain [9][10]. Registration and Participation - Participation in the conference is free, and there are opportunities for product exhibitions on-site [3][11]. - Registration links for various forums and events are provided for interested participants [11].

Core Viewpoint - The article discusses the upcoming Fourth China Plastic Surgery and Regenerative Medicine Development Conference and the 14th Beijing International Aesthetic Surgery Conference, scheduled for October 31 to November 2, 2025, in Beijing, aimed at promoting the development of plastic surgery in China and enhancing collaboration among related disciplines [3]. Event Details - The event will feature the Third Ba Da Chu Aesthetic Industry Forum, a competition final, and nine sub-forums [3]. - Participation is free, and there will be an exhibition of enterprise products on-site [4]. Organizers - The event is organized by Ba Da Chu Plastic Surgery Medical Concept Verification Center, Si Yu MedTech, Jin Yu Mao Wu, and Zi Niu Fund [5]. Agenda Highlights - The conference will include various presentations, such as: - "Current Status and Opportunities in the Medical Aesthetic Industry from an Investment Perspective" by Sun Hai Shun, Investment Vice General Manager, Jin Yu Mao Wu [6]. - "Development Trends in the Light Medical Aesthetic Industry from an Investment Perspective" by Yu Bo, Partner, Zi Niu Fund [6]. - "Application of Stem Cells and Exosomes in Postoperative Wound Repair" by Zhao Yong, Chairman, Bei Zheng Sai Ou (Beijing) Biotechnology Co., Ltd. [6]. - A roundtable forum is scheduled for discussion among experts [6]. Additional Sessions - Afternoon sessions will cover topics such as: - Non-invasive treatments supported by technology and the application of functional nucleic acid nanotechnology in the light medical aesthetic industry [7]. - New generation needle-free drug delivery technology in the medical aesthetic field [7]. - Development practices of high-end domestic laser medical equipment [7]. Target Audience - The conference aims to attract representatives from medical device and aesthetic enterprises, clinical doctors, researchers, investment institutions, regulatory experts, and industry observers [10].